Literature DB >> 26744558

Uncomplicated pneumonia in healthy Canadian children and youth: Practice points for management.

Nicole Le Saux, Joan L Robinson.   

Abstract

Although immunization has decreased the incidence of bacterial pneumonia in vaccinated children, pneumonia remains common in healthy children. Symptoms of bacterial pneumonia frequently overlap those present with viral infections or reactive airway disease. Optimally, the diagnosis of bacterial pneumonia should be supported by a chest radiograph before starting antimicrobials. Factors such as age, vital signs and other measures of illness severity are critical when deciding whether to admit a patient to hospital. Because Streptococcus pneumoniae continues to be the most common cause of bacterial pneumonia in children, prescribing amoxicillin or ampicillin for seven to 10 days remains the mainstay of empirical therapy for nonsevere pneumonia. If improvement does not occur, consideration should be given to searching for complications (empyema or lung abscess). Routine chest radiographs at the end of therapy are not recommended unless clinically indicated.

Entities:  

Keywords:  Antimicrobial therapy; Bacterial pneumonia; Viral pneumonia

Year:  2015        PMID: 26744558      PMCID: PMC4699530          DOI: 10.1093/pch/20.8.441

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN: 1205-7088            Impact factor:   2.253


  26 in total

1.  The use of antiviral drugs for influenza: Guidance for practitioners, 2012/2013; Paediatric summary.

Authors:  Upton D Allen
Journal:  Paediatr Child Health       Date:  2013-03       Impact factor: 2.253

2.  Diagnosis of childhood pneumonia: clinical assessment without radiological confirmation may lead to overtreatment.

Authors:  Deena Rachel Zimmerman; Nahum Kovalski; Scott Fields; Dimitry Lumelsky; Dan Miron
Journal:  Pediatr Emerg Care       Date:  2012-07       Impact factor: 1.454

Review 3.  Adverse reactions to β-lactam antimicrobials.

Authors:  Philippe Lagacé-Wiens; Ethan Rubinstein
Journal:  Expert Opin Drug Saf       Date:  2012-01-06       Impact factor: 4.250

Review 4.  Neuraminidase inhibitors for preventing and treating influenza in children (published trials only).

Authors:  Kay Wang; Matthew Shun-Shin; Peter Gill; Rafael Perera; Anthony Harnden
Journal:  Cochrane Database Syst Rev       Date:  2012-04-18

5.  Impact of a guideline on management of children hospitalized with community-acquired pneumonia.

Authors:  Ross E Newman; Erin B Hedican; Joshua C Herigon; David D Williams; Arthur R Williams; Jason G Newland
Journal:  Pediatrics       Date:  2012-02-20       Impact factor: 7.124

6.  Comparative effectiveness of empiric antibiotics for community-acquired pneumonia.

Authors:  Mary Ann Queen; Angela L Myers; Matthew Hall; Samir S Shah; Derek J Williams; Katherine A Auger; Karen E Jerardi; Angela M Statile; Joel S Tieder
Journal:  Pediatrics       Date:  2013-12-09       Impact factor: 7.124

7.  Neuraminidase inhibitors for critically ill children with influenza.

Authors:  Janice K Louie; Samuel Yang; Michael C Samuel; Timothy M Uyeki; Robert Schechter
Journal:  Pediatrics       Date:  2013-11-25       Impact factor: 7.124

Review 8.  Lung ultrasound for the diagnosis of pneumonia in children: a meta-analysis.

Authors:  Maria A Pereda; Miguel A Chavez; Catherine C Hooper-Miele; Robert H Gilman; Mark C Steinhoff; Laura E Ellington; Margaret Gross; Carrie Price; James M Tielsch; William Checkley
Journal:  Pediatrics       Date:  2015-03-16       Impact factor: 7.124

9.  Radiographic follow-up of pneumonia in children.

Authors:  R Virkki; T Juven; J Mertsola; O Ruuskanen
Journal:  Pediatr Pulmonol       Date:  2005-09

10.  Macrolide-resistant Mycoplasma pneumoniae in humans, Ontario, Canada, 2010-2011.

Authors:  AliReza Eshaghi; Nader Memari; Patrick Tang; Romy Olsha; David J Farrell; Donald E Low; Jonathan B Gubbay; Samir N Patel
Journal:  Emerg Infect Dis       Date:  2013       Impact factor: 6.883

View more
  10 in total

1.  Time to reconsider routine high-dose amoxicillin for community-acquired pneumonia in all Canadian children.

Authors:  Nipunie Srimalie Rajapakse; Joseph Varkey Vayalumkal; Otto Gerben Vanderkooi; Leah Jeanne Ricketson; James Duncan Kellner
Journal:  Paediatr Child Health       Date:  2016-03       Impact factor: 2.253

Review 2.  Short-course versus long-course oral antibiotic treatment for infections treated in outpatient settings: a review of systematic reviews.

Authors:  Elizabeth E Dawson-Hahn; Sharon Mickan; Igho Onakpoya; Nia Roberts; Matthew Kronman; Chris C Butler; Matthew J Thompson
Journal:  Fam Pract       Date:  2017-09-01       Impact factor: 2.267

3.  Research priorities for children with neurological impairment and medical complexity in high-income countries.

Authors:  Catherine Diskin; Kristina Malik; Peter J Gill; Nada Rashid; Carol Y Chan; Katherine E Nelson; Joanna Thomson; Jay Berry; Rishi Agrawal; Julia Orkin; Eyal Cohen
Journal:  Dev Med Child Neurol       Date:  2021-08-30       Impact factor: 4.864

4.  Zinc supplementation for pediatric pneumonia.

Authors:  Teeranai Sakulchit; Ran D Goldman
Journal:  Can Fam Physician       Date:  2017-10       Impact factor: 3.275

5.  Effect of Amoxicillin Dose and Treatment Duration on the Need for Antibiotic Re-treatment in Children With Community-Acquired Pneumonia: The CAP-IT Randomized Clinical Trial.

Authors:  Julia A Bielicki; Wolfgang Stöhr; Sam Barratt; David Dunn; Nishdha Naufal; Damian Roland; Kate Sturgeon; Adam Finn; Juan Pablo Rodriguez-Ruiz; Surbhi Malhotra-Kumar; Colin Powell; Saul N Faust; Anastasia E Alcock; Dani Hall; Gisela Robinson; Daniel B Hawcutt; Mark D Lyttle; Diana M Gibb; Mike Sharland
Journal:  JAMA       Date:  2021-11-02       Impact factor: 56.272

6.  Antibiotic use for community-acquired pneumonia in neonates and children: WHO evidence review.

Authors:  Shrey Mathur; Aline Fuchs; Julia Bielicki; Johannes Van Den Anker; Mike Sharland
Journal:  Paediatr Int Child Health       Date:  2018-11       Impact factor: 1.990

7.  Predictors of Treatment Outcomes among Pediatric Patients Hospitalized with Pneumonia in Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia.

Authors:  Hilina Tsegaw; Mohammed Yimam; Dejen Nureye; Workineh Woldeselassie; Solomon Hambisa
Journal:  Adv Pharmacol Pharm Sci       Date:  2021-04-20

8.  Macrolides (alone or in combination) should be used as first-line empirical therapy of community-acquired pneumonia in children: myth or maxim?

Authors:  Adilia Warris
Journal:  Breathe (Sheff)       Date:  2021-09

9.  Combined influence of practice guidelines and prospective audit and feedback stewardship on antimicrobial treatment of community-acquired pneumonia and empyema in children: 2012 to 2016.

Authors:  Nicole M A Le Saux; Jennifer Bowes; Isabelle Viel-Thériault; Nisha Thampi; Julie Blackburn; Melanie Buba; Mary-Ann Harrison; Nick Barrowman
Journal:  Paediatr Child Health       Date:  2020-06-30       Impact factor: 2.253

10.  Paediatric critical illness associated with respiratory infection: a single-centre, retrospective cohort study.

Authors:  Haifa Alfaraidi; Kathy Luinstra; Alireza Eshaghi; Marek Smieja; Jonathan B Gubbay; Jeffrey M Pernica
Journal:  BMJ Paediatr Open       Date:  2020-04-27
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.